A detailed history of Round Rock Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Round Rock Advisors, LLC holds 3,500 shares of NVS stock, worth $344,225. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,500
Previous 3,500 -0.0%
Holding current value
$344,225
Previous $372,000 8.06%
% of portfolio
0.09%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

SELL
$92.27 - $101.54 $7,842 - $8,630
-85 Reduced 2.37%
3,500 $353,000
Q1 2023

May 02, 2023

BUY
$80.03 - $92.81 $6,802 - $7,888
85 Added 2.43%
3,585 $329,000
Q2 2022

Jul 22, 2022

BUY
$80.52 - $93.75 $43,480 - $50,625
540 Added 18.24%
3,500 $296,000
Q1 2022

Apr 28, 2022

BUY
$80.11 - $90.62 $237,125 - $268,235
2,960 New
2,960 $260,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Round Rock Advisors, LLC Portfolio

Follow Round Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Rock Advisors, LLC with notifications on news.